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Abstract
It is well documented that thymic epithelial cells participate in the process of negative selection in the thymus. In recent
years it was reported that also dendritic cells enter the thymus and contribute to this process, thus allowing for the
depletion of thymocytes that are specific to peripherally expressed self-antigens. Here we report that also B cells may take
part in the elimination of auto-reactive thymocytes. Using a unique mouse model we show that B cells induce negative
selection of self-reactive thymocytes in a process that leads to the deletion of these cells whereas regulatory T cells are
spared. These findings have direct implication in autoimmunity, as expression of a myelin antigen by B cells in the thymus
renders the mice resistant to autoimmune inflammation of the CNS.
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Introduction
A critical step in the development of immunological tolerance is
the exposure of immature T cells to self-peptide/MHC in the
thymus. The clonal deletion of auto-reactive thymocytes in this
process (negative selection) is one way to achieve tolerance and is
supposed to be the major mechanism of immunological tolerance,
given the fact that mice and humans deficient for the
transcriptional regulator AIRE show an impaired clonal deletion
in the thymus and suffer from multiorgan autoimmune disease [1],
[2], [3], [4]. Studies in different mouse models [5], [6] have shown
that particularly medullary thymic epithelial cells (mTECs) present
a plethora of different autoantigens that are otherwise expressed in
a tissue-specific manner. This phenomenon referred to as
promiscuous gene expression is crucial for thymic negative
selection of self-reactive T cells [7], [8]. Besides mTECs, BM-
derived MHCII-expressing antigen presenting cells (APC) such as
macrophages, dendritic cells (DCs) and also B cells reside the
thymus and are thus potential participants in negative selection.
Thymic macrophages were shown to be most likely unable to
perform negative selection of autoreactive thymocytes [9] but they
were described to rather function in the clearing of apoptotic cells
[10], [11]. In addition to mTECs, also DCs were proposed to be
important contributors to negative selection in the thymus [12],
[13]. To evaluate the role of DCs in negative selection, MHCII
2/2
BM chimeras were used [14], [15]. Mice with an absent antigen
presentation by DCs due to the lack of MHCII show an impaired
negative selection of CD4
+ thymocytes, indicated by the fact that
MHCII
2/2 chimeras exhibit increased numbers of self-reactive
CD4
+ thymocytes [16]. Another study using mice depleted of DCs
shows an impaired negative selection of CD4
+ T cells [17].
Additionally, DCs were also demonstrated to be able to participate
in negative selection of CD8
+ T cells [18].
The role of B cells in negative selection of thymocytes was only
scarcely studied before. These cells were shown to participate in
partial negative selection of CD4
+ T cells [18]. In this study, a B
cell-specific expression system of the MHCII I-Ea gene in an I-E
negative background was used and thereby shown that thymic B
cells are able to negatively select self-I-E-reactive CD4
+ T cells
[18].
To further address the importance of B cells in negative
selection of autoreactive thymocytes and the generation of
regulatory T cells in the thymus we made use of a mouse model
that is characterized by the presentation of the self-peptide 35–55
of myelin oligodendrocyte glycoprotein (MOGp35-55) specifically
on MHCII of B cells (B
MOG mice; [19]). These mice were crossed
to MOG-specific T cell receptor (TCR) tg mice (2D2 mice; [20])
resulting in a mouse strain that combines the specific presentation
of MOGp35-55 on B cells with a MOG-specific T cell repertoire.
The presentation of MOGp35-55 on all B cells including thymic B
cells in this mouse model makes it suitable to study the impact of B
cells on thymocytes and their role in thymic negative selection. In
these mice we observed a strong deletion of MOG-specific CD4
+
transgenic T cells leading to the nearly entire absence of transgenic
T cells in the periphery. In contrast, regulatory T cells seemed to
be exempted from deletion as the proportion of CD4
+Foxp3
+ T
cells in these mice was found to be increased.
Results
B cell-specific presentation of MOG peptide in the
thymus leads to negative selection of MOG-specific T
cells
Of all cells that express constitutively MHC class II molecules
(MHCII), B cells are the most abundant in the body. In the mouse,
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(APCs) in almost all tissues. B cells can also be found in the
thymus, where most of them acquire a phenotype resembling B-1a
cells, namely the expression of CD5 and CD44 [21]. We have
previously demonstrated that B cells, when forced to present an
autoantigen, can participate in the process of peripheral tolerance
[19]. Once B cells encounter naı ¨ve T cells that recognize the
peptide presented on MHCII, these T cells will become only
partially activated and subsequently sensitive to the process of
antigen-induced cell death. As B cells are also present in the
thymus, we set to investigate whether they may participate also in
the process of central tolerance. To answer this question, we made
use of the B
MOG mice, where B cells constitutively present the
MOG peptide p35-55 on MHCII [19]. These mice were crossed
to 2D2 mice [20] that express a MOGp35-55-specific T cell
receptor (TCR), forming the B
MOG/2D2 mouse strain. To
investigate whether constitutive expression of an autoantigen
influences the process of thymocyte education, we analyzed thymi
of B
MOG/2D2 mice compared to thymi of 2D2 single transgenic
mice. As can be seen in Fig. 1A, about half of the cells in the
thymus of 2D2 mice are double positive (DP) for CD4 and CD8,
and a third of the cells are CD4 single positive (SP). The relatively
low percentage of DP and high percentage of CD4 SP T cells
reflects, most likely, the very high efficiency of the MOG-specific
TCR expression in these mice, as the latter was originally isolated
from a CD4
+ T cell clone [20]. In contrast, the number of SP CD4
T cells in the thymi of B
MOG/2D2 mice was drastically reduced
(Fig. 1A and B). Importantly, we also found a drastic reduction of
CD4
+ T cells in the lymph nodes (LN) (Fig. 1A and C) as well as
spleens (not shown) of B
MOG/2D2 mice. The total cell number of
CD8
+ T cells in these mice was only slightly but not significantly
increased (data not shown). Further, we observed that the number
of CD4 T cells that do not express the transgenic Va3.2 chain is
slightly elevated in LN of B
MOG/2D2 mice when compared to
2D2 single transgenic mice (Fig. 1C). These findings suggest that B
cells presenting self-antigen participate in the process of negative
selection in the thymus by inducing the death of self-reactive T
cells. In addition, these data indicate that during this process no
significant levels of TCR editing can be found, as the latter should




in both thymus and LN.
Negative selection of 2D2 T cells is due to MOG
presentation by B cells and not by unspecific Cre activity
of other thymic APCs
We were wondering whether the very efficient negative selection
we observed in the thymi of B
MOG/2D2 mice is in fact the result of
peptide expression by other APCs in the thymus. Previously, we
have ruled out the possibility that DCs and macrophages in the
B
MOG mice present the MOG peptide, as we found that they were
not able to trigger 2D2 TCR expressing cells in vitro [19]. But in
the thymus, there are specialized cells, such as medullary thymic
epithelial cells (mTEC) that participate in the process of negative
selection, implicating the risk of unspecific MOG presentation in
the thymus. To investigate whether the Cre-recombinase in B
MOG
mice is unspecifically expressed in cells other than B cells, and
therefore leads to negative selection by non-B cells, we crossed
B
MOG/2D2 mice to B cell-deficient JHT mice. In JHT mice, the
whole JH locus was deleted using the Cre/loxP system, leading to
mice that are not capable to rearrange the heavy chain locus, and
are therefore absolutely devoid of B cells [22]. As seen in Fig. 2,
B
MOG/2D2 mice crossed to the JHT mutant mice show a T cell
development that is comparable to that of 2D2 WT mice. These
findings demonstrate that the negative selection seen in B
MOG/
2D2 mice is indeed the result of the MOG peptide presented by
MHCII of B cells, and not by unspecific expression of CD19-Cre,
that would lead to Cre expression and thus MOG presentation by
non-B cells in the thymus.
T cells that escape negative selection express lower
levels of the transgenic b chain
The number of CD4
+Va3.2
+ T cells is dramatically reduced in
the LN of B
MOG/2D2 compared to 2D2 mice (Fig. 1 and 3).
Interestingly, all surviving cells additionally still express the
transgenic TCR b chain, namely Vb11 (Fig. 3). But the expression
levels of the TCR Vb11 are reduced in mice where B cells present
the MOG peptide (see histogram in Fig. 3). These findings suggest
that the remaining transgenic TCR-expressing T cells can
recognize the MOG peptide presented by B cells in the periphery,
as reduced TCR expression is an indicative of recent T cell
activation.
Thymic regulatory T cells are spared from negative
selection by B cells
It was suggested that Foxp3 expression and thus development
and function of regulatory T cells are dependent on the strength of
TCR signaling during thymic selection [23]. To investigate
whether the expression of self-peptide by B cells influences the
number of regulatory T cells in the thymus, we analyzed the
proportion of Foxp3
+ T cells in B
MOG/2D2 mice. As can be seen
in Fig. 4A, the percentage of Foxp3
+ T cells in the thymus of 2D2
mice is minimal, and accounts for only 0.5% of all CD4
+ T cells.
In contrast, we observed a 10-fold increase of Foxp3
+ T cells in the
thymus of B
MOG/2D2 mice (Fig. 4A). Importantly, this increase is
not due to increased total numbers of these cells (Fig. 4B), but
reflects the decrease of the Foxp3
2 T cell population. As can be
seen in Fig. 4C (and Fig. 1–3), very few CD4
+Va3.2
+ T cells can
be found in the LN of B
MOG/2D2 mice when compared to LN of
2D2 WT mice. The decrease of MOG-specific T cells in the
peripheral lymphoid organs of B
MOG/2D2 mice is most likely due
to the decrease in MOG-specific CD4
+ T cells in the thymus of
these mice, and as mentioned above, is suggested to occur upon
deletion of antigen-specific T cells that encounter B cells
presenting the MOG peptide in the thymus. Interestingly, when
we analyzed the percentage of Foxp3
+ T cells among the Va3.2-
expressing and non-expressing T cells, we found that in single
transgenic 2D2 mice, a large proportion of Va3.2 negative cells
express this essential regulatory T cell transcription factor (Fig. 4C).
In fact, this proportion, 27%, is much higher than normally seen
in WT mice. It is a strong indication that the process of TCR
editing in the thymus is coupled to the process of regulatory T cell
generation. This proportion of Foxp3-expressing T cells among
the Va3.2 negative cells is slightly increased in B
MOG/2D2 mice
(Fig. 4C). But most importantly, the proportion of Foxp3-
expressing T cells among the Va3.2-expressing T cells is also
greatly enhanced (Fig. 4C), leading to mice in which about a third
of all CD4
+ T cells are Foxp3
+.
Peripheral T cells that have escaped negative selection
by B cells are anergic
We have shown that B cells presenting the MOG peptide by
MHCII can participate in the process of negative selection, leading
to mice with very few T cells expressing the transgenic TCR. Next,
we investigated whether the relatively few remaining T cells are
capable of recognizing the MOG peptide in vivo, or whether they
are anergic. To this end, we have isolated T cells from LN and
spleen of B
MOG/2D2 mice and transferred them into mice where
B Cells Participate in Thymic Negative Selection
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+ T cells upon MOG encounter by B cells in the thymus. Thymus and LN from WT 2D2 (upper row) and B
MOG/
2D2 (lower row) mice were analyzed by FACS analysis for presence of CD8
+ and CD4
+ Va3.2
+ T cells, respectively (A). Genotypes and antibodies used
are as indicated. Cell surface markers are shown as coordinates. Cells were gated on live lymphocytes. Numbers besides gates or in quadrants indicate
percent positive cells in each. Total and CD4 single positive thymocyte numbers (B) and LN total CD4





numbers (C) of 2D2 and B
MOG/2D2 mice were calculated. Values represent mean 6 SEM. ns, not significant.
doi:10.1371/journal.pone.0015372.g001
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MOG [19]). As a
control, we transferred CD4
+ T cells isolated from 2D2 mice. As
can be seen in Fig. 5A, T cells of 2D2 mice proliferated extensively
once transferred to mice where the MOG peptide is expressed by
all APCs, as we have demonstrated previously [19]. In contrast, we
could not detect proliferation of T cells from B
MOG/2D2 mice,
and they behaved identically when transferred to mice where the
MOG peptide is not expressed (Fig. 5A). Finally, we have
attempted to induce EAE in B
MOG/2D2 mice. Normally, 2D2
mice are highly susceptible to the MOG-induced disease, as the
vast majority of the naı ¨ve T cell repertoire in these mice is MOG-
specific [20]. Indeed, we noted that the 2D2 mice all developed
EAE, once immunized with the MOG peptide (Fig. 5B). In
contrast, B
MOG/2D2 mice were completely resistant to EAE
induction (Fig. 5B). These data indicate that the relatively low
number of CD4
+ T cells that remain in B
MOG/2D2 mice are
either tolerized or their number is just not sufficient for disease
induction and as a result, not able to induce the development of
EAE.
Discussion
Elimination of self-reactive T cells in the thymus is a critical
mechanism of immunological tolerance. B cells can be found in
the thymus, but their participation in negative selection of self-
reactive thymocytes has been poorly addressed. In his study, we
show that B cells that are enforced to present an autoantigen by
their MHCII molecules induce strong deletion of self-reactive T
cells and that this process results in complete resistance to EAE.
Further, we demonstrate that the process of negative selection by B
cells is solely effective for conventional CD4
+ T cells, but spares
regulatory CD4
+FoxP3
+ T cells, thus resulting in an imbalance
between effector and regulatory T cells.
Promiscuous gene expression by mTECs was shown to be
crucial for thymic negative selection of self-reactive T cells [6], [7],
[8], but also thymic DCs have an important role in negative
selection [14], [18], [24]. In contrast, conventional B-2 as well as
B-1 B cells have previously been reported to reside in the thymus
[21], but their exact function was not clearly shown. We have
demonstrated that B cells that are engineered to express the MOG
peptide p35-55 on MHCII interact with MOG-specific CD4
+ 2D2
T cells in a process that eventually results in the deletion of naı ¨ve T
cells, as in the periphery of these mice only few MOG-specific T
cells can be found. However, a role of B cells in thymic negative
selection was so far only clearly evidenced by [18]. In this study,
they targeted expression of I-Ea self-antigen to the B cell lineage
using the human CD19 promoter and studied negative selection in
the I-E negative C57Bl/6 background. Depending on the TCR b
Figure 2. Deletion of 2D2 CD4
+ T cells in the thymus is specifically induced by B cells. LN of 2D2 and 2D2/JHT (left row) as well as B
MOG/
2D2 and B
MOG/2D2/JHT (right row) mice were analyzed by FACS analysis for presence of CD4
+ Va3.2
+ T cells. Genotypes and antibodies used are as
indicated. Cell surface markers are shown as coordinates. Cells were gated on live lymphocytes. Numbers besides gates or in quadrants indicate
percent positive cells in each.
doi:10.1371/journal.pone.0015372.g002
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+ T cells of 36 up to 42%
[18].
Our study not only shows a partial deletion of self-reactive T cells
but the nearly entire elimination of MOG-specific T cells in B
MOG
mice. Indeed, the deletion accounts for over 95% of T cells in
B
MOG/2D2 mice when compared to 2D2 controls. This strong
effectmight display the potential importanceofB cellsinthe process
of negative selection or might in part also be due to the high
proportion of B cells presenting the peptide on MHCII. However,
the number of B cells in the thymus is generally not high (less than
1% of total lymphocytes; [21]). Thus, we speculate that the strong
deletion of 2D2 T cells in B
MOG/2D2 mice results from the B cells’
potential of negatively selecting self-reactive thymocytes.
Although CD19-Cre mice were generated over 20 years ago
[25] and successfully used in numerous studies since then [26],
[27], [28], [29], [19] the use of Cre-expressing mouse strains
carries along the risk of unspecific Cre activity in cell types other
than the requested ones and thus might lead to misleading results
[30]. To exclude this possibility, we crossed B
MOG/2D2 mice on a
B cell-deficient background using JHT mice [22] and compared
CD4
+ T cell development in the thymus of these mice to all
controls. We could demonstrate normal CD4
+ T cell development
(comparable to 2D2 WT mice) and no negative selection of MOG-
specific T cells in B
MOG/2D2/JHT mice and thus concluded that
negative selection in B
MOG/2D2 mice is indeed due to Cre
expression in B cells of these mice and not due to unspecific Cre
activity in other cell types of the thymus.
As seen in Fig. 1, 3 and 4, we noted a population of
Va3.2
+CD4
2 T cells in LN of both, 2D2 and B
MOG/2D2 mice.
The percentage, but not the total cell number of this population is
increased in B
MOG/2D2 mice compared to 2D2 WT mice and
generally varies between independent experiments. Moreover,
these cells are CD8
2 (data not shown). This phenomenon was seen
for different TCR transgenic mice, especially for those carrying an
autoreactive TCR and these cells were shown to be
TCRab
+CD4
2 and either CD8
low or CD8
2 [31]. It was
considered that these cells are cd T cells that never accomplished
cd TCR rearrangement, but are instead positive for the transgenic
ab TCR chain (‘cd wannabe T cells’, [31]). Since such a
population was found in HY TCR transgenic males (where HY-
specific T cells are negatively selected) it was speculated that these
cells might be escapees from negative selection [31]. Accordingly,
the population of Va3.2
+CD4
2CD8
2 cells, which we observe
notably in B
MOG/2D2 mice, might be T cells that have escaped
negative selection by B cells.
Importantly, we also analyzed B
MOG/2D2 mice for the
development of EAE after standard immunization with
MOGp35-55 and observed all of these mice being completely
resistant to disease. The resistance is probably due to the fact, that
over 95% of the MOG-specific T cell are deleted in the thymi of
B
MOG/2D2 mice, thus leaving behind T cell numbers that are not
sufficient for the development of EAE. However, some T cells
escape negative selection by B cells. To investigate whether these
cells are still functional, we subjected them to stimulation with
Figure 3. Residual MOG-specific T cells in B
MOG/2D2 mice downregulate Vb11. LN of WT 2D2 and B
MOG/2D2 mice were analyzed by FACS
analysis for presence of CD4, Va3.2 and Vb11. Cells were analyzed for expression of Va3.2 vs CD4 (dot blots). Cells were then gated on CD4
+ Va3.2
+ T
cells and the percentage of Vb11-expressing cells among this population is shown by histogram overlay. The red line in the histograms refers to the
red gate of CD4
+ Va3.2
+ cells in 2D2 mice, the blue line refers to CD4
+ Va3.2
+ cells (blue gate) of B
MOG/2D2 mice. Colored numbers above the marker
line indicate MFI (mean fluorescence intensity) of anti-Vb11-PE for the respective populations.
doi:10.1371/journal.pone.0015372.g003
B Cells Participate in Thymic Negative Selection
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MOG mice). The remaining
MOG-specific T cells were not able to proliferate when stimulated
in vivo by MOG-presenting APCs. This is in line with our
previously published results where we showed that B cells induce
peripheral tolerance of auto-reactive T cells [19].
Our study further extends to the analysis of regulatory T cells
(Tregs) and we observed that the population of CD4
+Foxp3
+
Tregs remains apparently unaffected in our experimental mice.
Consequently, we noted an increased proportion but unchanged
total cell numbers of Tregs since the auto-reactive MOG-specific
T cells were deleted but not the Tregs. Due to the fact that the
total cell numbers are unaltered, we conclude that Tregs are more
resistant to apoptosis and thus accumulate when self-reactive
conventional T cells are negatively selected. Whether or not Tregs
are more apoptosis-resistant was under debate in the last years and
some studies reported a normal sensitivity of Tregs to thymic
deletion [32], [33]. However, in line with our data, it was shown
that CD4
+CD25
+ thymocytes are much less sensitive to agonist-
induced clonal deletion than CD4
+CD25
2 thymocytes [34]. This
explains the accumulation of Tregs in the presence of agonist
Figure 4. FACS analysis of Foxp3-expressing T cells in B
MOG/2D2 mice. (A) Thymus and LN of WT 2D2 and B
MOG/2D2 mice were analyzed for
expression of Foxp3 by intracellular FACS staining. Genotypes and antibodies used are as indicated. Cells were gated on CD4
+ cells. Numbers in
quadrants indicate percent positive cells. (B) Total numbers of CD4
+ Foxp3
+ T cells from thymus and LN were calculated. Data represent mean values
6 SEM of several individual experiments. ns, not significant. (C) LN cells from B
MOG/2D2 and WT 2D2 mice were gated on CD4
+ Va3.2
+ or CD4+ Va3.2
2
T cells, respectively, and percentage of Foxp3-expressing cells among these populations is shown by histograms. The blue line in the histograms
refers to the blue gate of CD4
+ Va3.2
2 cells, the red line refers to CD4
+ Va3.2
+ cells (red gate). Colored numbers above the marker line indicate
percent positive cells for the respective populations.
doi:10.1371/journal.pone.0015372.g004
B Cells Participate in Thymic Negative Selection
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apoptosis, rather than to induced differentiation. Also, a study by
Taylor et al. showed self-reactive Tregs being moderately resistant
to TCR-mediated apoptosis, resulting in a bias of Treg TCRs
towards autoreactivity in comparison to TCRs of conventional T
cells [35]. Our data suggests that the elevated Treg proportions in
B
MOG/2D2 mice account for their relative resistance to apoptosis
while conventional T cells are deleted due to the MOG
presentation by B cells.
Materials and Methods
Mice
All animal experiments were in accordance with the guidelines
of the central animal facility institution (ZVTE, University of
Mainz), and approved accordingly to animal protection law with
permissions number AZ 177-07/051-2. 2D2, CD19-Cre and
IiMOG mice were described elsewhere [20], [25], [19]. DNA for
typing was prepared from tail biopsies. Presence of the different
Figure 5. (A) 2D2 CD4
+ T cells from B
MOG/2D2 mice do not proliferate upon in vivo MOG stimulation. CD4
+ Thy1.1
+ T cells from WT 2D2
and B
MOG/2D2 mice were MACS-purified, CFSE-labeled, and transferred to APC
MOG mice (,10610
6/mouse). Prior to transfer, APC
MOG mice were
injected with anti-CD40. Five days after transfer, cells were monitored for proliferation by FACS analysis and loss of CFSE is depicted by representative
dot blots of LN cells. Genotypes and antibodies used are as indicated. Cell surface markers are shown as coordinates. Cells were gated on live
lymphocytes. (B) B
MOG/2D2 mice are resistant to EAE. EAE was actively induced by immunization of 2D2 (squares) and B
MOG/2D2 (circles) mice
with MOGp35-55. B
MOG/2D2 mice are protected from EAE compared to 2D2 WT mice (p,0,05: days 12–27). Values represent mean (6 SEM) clinical
scores. Shown is one representative of two individual experiments (n$4 mice/group).
doi:10.1371/journal.pone.0015372.g005
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[25,36], 2D2 [20] and IiMOG mice [19]. All experiments were
performed with 6–12 weeks old mice. The experiments were
repeated at least once.
Cell preparations and CFSE staining
2D2 CD4
+ T cells were isolated from spleen and LN by positive
selection using MACS (Miltenyi Biotech) according to the
manufacturer’s instructions. Purity of the resulting CD4
+ T cells
was typically .95%. When indicated freshly isolated CD4
+ T cells
from 2D2 mice were labeled with the vital dye CFSE (Molecular
Probes). After washing the cells twice in 10 ml PBS, pH 7.4, they
were incubated with 0.5 mM CFSE in 1 ml PBS per 10
7 cells at
RT for 8 min. To stop the staining reaction 8 ml RPMI plus 10%
FCS was added. The cells were then washed twice in 10 ml RPMI,
resuspended in the appropriate volume of PBS and typically 5–
10610
6 T cells were injected i.v. into the different mice as
indicated. When indicated recipient mice received an i.p. injection
of 50 mg agonistic anti-CD40 (FGK45.5, [37], homemade).
Flow cytometry
For cytofluorometric analysis we used Ab conjugates to the
following antigens: CD4, CD8, Thy1.1, Va3.2, Vb11. Antibodies
were obtained from BD Pharmingen or Natutec (eBiosciences).
Intracellular stainings for Foxp3 were performed using the Foxp3
Staining Set (Natutec, eBiosciences) according to the manufactur-
er’s instructions. Cells from lymphoid organs were stained with the
Ab conjugates for flow cytometric analysis on a FACSCalibur or a
FACScan (BD Biosciences). Events in a live lymphocyte gate were
analyzed with CellQuest (BD Biosciences) software.
Induction and assessment of EAE
MOG35–55 peptide (amino acid sequence: MEVGWYR-
SPFSRVVHLYRNGK) was obtained from Research Genetics.
Active EAE was induced by immunization with 50 mg of MOG35–
55 peptide emulsified in CFA (Difco Laboratories) supplemented
with 10 mg/ml of heat-inactivated Mycobacterium tuberculosis
H37RA (Difco Laboratories). The emulsion was administered as
a 100 ml subcutaneous injection in the tail base. Mice also received
200 ng of pertussis toxin (Sigma Aldrich) intraperitoneally (i.p.) on
the day of immunization and 2 days later. Clinical assessment of
EAE was performed daily according to the following criteria: 0, no
disease; 1, decreased tail tone; 2, abnormal gait (ataxia) and/or
impaired righting reflex (hind limb weakness or partial paralysis);
3, partial hind limb paralysis; 4, complete hind limb paralysis; 5,
hind limb paralysis with partial fore limp paralysis; 6, moribund or
dead.
Statistics
Values are presented as mean 6 SEM. Statistical significance
was assessed using 2-tailed Student’s t-test. p-values ,0.05 were
regarded significant.
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